Not yet recruiting
Obesity
Not yet recruitingInvestigational
KAI-9531 in Adults With Obesity or Overweight and Diabetes
Investigational
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:HRS 9531
Back to SpainClinical trials in Villamartin – page 2
22 clinical trials in Villamartin, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Villamartin at a glance
22
clinical trials
- Paediatric trials0
- Research sites0
Not yet recruiting
Arteriosclerosis
Not yet recruitingInvestigational
A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
Investigational
- Disease:Arteriosclerosis
- Substances:–
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Sponsor:Eli Lilly & Co.
Not yet recruiting
Arteriosclerosis
Not yet recruitingInvestigational
Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
Investigational
- Disease:Arteriosclerosis
- Substances:–
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Not yet recruiting
Atrial fibrillation
Not yet recruitingInvestigational
Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
Investigational
- Disease:Atrial fibrillation
- Substances:Regn7508Regn9933
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Regn7508
- Sponsor:Regeneron Pharmaceuticals Inc.
Not recruiting
Arteriosclerosis
Not recruitingRegistered drug
Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
Registered drug
- Disease:Arteriosclerosis
- Substances:AtorvastatinInclisiran+1
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Atorvastatin
- Sponsor:Novartis Pharma AG
Not recruiting
Arteriosclerosis
Not recruitingRegistered drug
Study on Inclisiran for Preventing Heart Disease in High-Risk Patients
Registered drug
- Disease:Arteriosclerosis
- Substances:Inclisiran
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Not recruiting
Chronic kidney disease+1
Not recruitingInvestigational
A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
Investigational
- Disease:Chronic kidney diseaseArteriosclerosis
- Substances:Ziltivekimab
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Ziltivekimab
- Sponsor:Novo Nordisk A/S
Not recruiting
Obesity+1
Not recruitingInvestigational
Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues
Investigational
- Disease:ObesityOverweight
- Substances:–
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Sponsor:Eli Lilly & Co.
Not recruiting
Atrial fibrillation+2
Not recruitingRegistered drug
Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
Registered drug
- Disease:Atrial fibrillationThrombosis prophylaxis+1
- Substances:ApixabanAsundexian
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Apixaban
- Sponsor:Bayer AG
Not recruiting
Cardiovascular disorder+1
Not recruitingInvestigational
Study on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease
Investigational
- Disease:Cardiovascular disorderObesity
- Substances:Ly3437943 Sodium
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Ly3437943 Sodium
- Sponsor:Eli Lilly & Co.
Other cities in Spain
The busiest research cities in the country
- Madrid3 290 trials · 24 research sites
- Barcelona3 139 trials · 23 research sites
- Valencia1 779 trials · 8 research sites
- Sevilla1 638 trials · 4 research sites
- Malaga1 051 trials · 4 research sites
- L'hospitalet De Llobregat979 trials · 4 research sites
- Badalona769 trials · 3 research sites
- Pamplona753 trials · 1 research site
Clinical research in Villamartin
What the registry says about research in the country
01 Cardiovascular Research
Groundbreaking studies focusing on cardiovascular disease prevention and treatment, particularly examining new therapies for stroke prevention in patients with atrial fibrillation and innovative treatments for heart failure.
- Atherosclerotic cardiovascular disease
- Heart failure management
- Stroke prevention
Multiple trials evaluating novel compounds like asundexian and inclisiran for improving cardiovascular outcomes.
02 Metabolic Disorders
Advanced research into Type 2 Diabetes Mellitus management, comparing innovative treatments like tirzepatide with established therapies to assess cardiovascular outcomes and glycemic control.
- Diabetes management
- Cardiovascular risk reduction
- Metabolic health optimization
Comprehensive studies aimed at improving treatment options for patients with metabolic disorders.
03 Weight Management
Innovative clinical trials examining new therapeutic approaches for obesity and overweight conditions, including studies of orforglipron and retatrutide for weight management.
- Obesity treatment
- Weight-related comorbidities
- Metabolic health
Research focusing on developing effective treatments for weight management while addressing associated health risks.